Optimal glycemic control remains challenging and elusive for many people with diabetes.
With the comprehensive clinical evidence on safety and efficiency in large populations, and …

The promotion of continuous glucose monitoring (CGM) to standard of care for type 1
diabetes and insulin-treated type 2 diabetes reflects a robust and wide evidence base for the …

Background: To analyze key indicators of metabolic control in adults with type 1 diabetes
(T1D) using real-time or intermittent scanning continuous glucose monitoring …

Investigating the daily life experiences of patients using Continuous Glucose Monitoring
(CGM) can highlight the benefits and barriers in using this system for people with type 1 …

To enhance the digital competencies of pharmacy students, the Institute of Clinical
Pharmacy and Pharmacotherapy at Heinrich-Heine University Duesseldorf developed and …

Cell-based therapies are emerging for type I diabetes mellitus (T1D), an autoimmune
disease characterized by the destruction of insulin-producing pancreatic β-cells, as a means …

Diabetes is a widespread disease characterized by high blood glucose levels due to
abnormal insulin activity, production, or both. Chronic diabetes causes many secondary …

Introduction: Immune checkpoint inhibitor-associated diabetes mellitus (ICI-DM) is a rare
adverse event. In this study, we characterize clinical outcomes of patients with ICI-DM and …

The recent development of reliable systems for continuously monitoring interstitial glucose
levels has set the stage for a revolution in diabetes research and care. The ability to obtain …

Objective: Determine whether continuous glucose monitor (CGM) metrics can provide
actionable advance warning of an emergency department (ED) visit or hospitalization for …